Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1016 (LINC01016)

Target
LINC01016
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1016 (LINC01016) is a long non-coding RNA (lncRNA) gene located on chromosome 6q21.31 and is expressed as multiple isoforms, particularly abundant in testis and variably expressed in several tissues and cancers[1][5]. LINC01016 has been mechanistically linked to the promotion of cell proliferation, migration, and invasion in several cancers, including gastric, breast, endometrial, testicular, and cervical cancer. Its oncogenic effects are mediated through various mechanisms, such as binding to proteins (e.g., binds EIF4A3, thereby regulating nonsense-mediated RNA decay and increasing MMP9 expression, or DHX9, stabilizing it and enhancing signaling pathways like PI3K/AKT)[1][2][3]. LINC01016 expression correlates with poor prognosis, metastatic potential, and relapse in gastric cancer and other tumors, making it a putative therapeutic and diagnostic target. However, there are currently no known drugs that directly target LINC01016, and its context-specific isoform expression poses additional therapeutic challenges[5].

Other names
LncRNA1195long intergenic noncoding RNA 01016
02

Biological functions

Regulation of cell proliferationRegulation of cell migrationRegulation of cell invasionModulation of apoptosisGene expression regulationRegulation of nonsense-mediated RNA decayProtein binding (e.g., binds EIF4A3, DHX9)
03

Disease associations

CancerTumor progression
04

Safety considerations

Isoform- and tissue-specific expression may pose challenges for therapeutic targetingPotential off-target effects if targeting globally expressed lncRNA isoforms
05

Biomarkers

Prognostic marker for relapse-free and overall survival in gastric cancerPrognostic marker in breast, testicular, cervical, and uterine cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1016 (LINC01016).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1016 (LINC01016).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call